Peng Liu

机构：Shenyang Pharmaceutical University, Jiangsu University, Tianjin University of Science and Technology, Capital Medical University, Tianjin Economic-Technological Development Area, Jiangsu Agri-animal Husbandry Vocational College, Beijing Institute of Neurosurgery · ORCID：0000-0002-8580-3763

发表论文 144 篇 · 总被引 3308 次 · h-index 32

代表论文

• Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer (2023 · Journal for ImmunoTherapy of Cancer · 被引 26)
• Identification and functional characterization of caspases in turbot (Scophthalmus maximus) in response to bacterial infection (2023 · Fish & Shellfish Immunology · 被引 11)
• IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway (2024 · World Journal of Surgical Oncology · 被引 10)
• Precipitated-crosslinked multi-enzyme hybrid nanoflowers for efficient synthesis of α-ketoglutaric acid (2024 · International Journal of Biological Macromolecules · 被引 7)
• Structural insights into the binding of nanobodies to the Staphylococcal enterotoxin B (2024 · International Journal of Biological Macromolecules · 被引 7)
• Prevalence, characteristics, and associated risk factors of plantar heel pain in americans : The cross-sectional NHANES study (2024 · Journal of Orthopaedic Surgery and Research · 被引 6)